CHI-25243

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCHI-25243
Drug Alias NameCHI-25243
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasisCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesChiesi Farmaceutici SPA
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasisCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A